Concepedia

Author

Christina Demuth

Aarhus University HospitalORCID

Also Known As

C Demuth, C. D. Demuth, C. Demuth, Christina Demuth, Demuth, Christina; id_orcid 0000-0003-0237-9758

71

Publications

916

Citations

16

H-Index

29

Concepts

All Affiliations

Aarhus University HospitalAarhus UniversityRegionshospitalet HerningOdense University HospitalRegional Hospital Horsens
CD

About

Christina Demuth is an author at Aarhus University Hospital specializing in medicine, oncology, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

330

2

Health Sciences

3

3

167

3

Cell Biology

2

2

97

4

Immunology

2

2

128

5

Hepatology

1

1

70

Christina Demuth

×

22

Publications

786

Citations

16

H-Index

YearCitations

Increase in soluble PD-1 is associated with prolonged survival in patients with advanced EGFR -mutated non-small cell lung cancer treated with erlotinib

Steffen Filskov Sorensen, Christina Demuth, Britta Weber,

Lung Cancer

2016

111

MET amplification and epithelial-to-mesenchymal transition exist as parallel resistance mechanisms in erlotinib-resistant, EGFR-mutated, NSCLC HCC827 cells

Kristine Raaby Jakobsen, Christina Demuth, Anne Tranberg Madsen,

Oncogenesis

2017

80

Measuring KRAS Mutations in Circulating Tumor DNA by Droplet Digital PCR and Next-Generation Sequencing

Christina Demuth, Karen‐Lise Garm Spindler, Julia S. Johansen,

Translational Oncology

2018

72

Evaluation of VEGF A expression and microvascular density as prognostic factors in extrahepatic cholangiocarcinoma

Christian Möbius, Christina Demuth, Thomas Aigner,

European Journal of Surgical Oncology

2007

70

Unraveling the potential clinical utility of circulating tumor DNA detection in colorectal cancer—evaluation in a nationwide Danish cohort

Tenna Vesterman Henriksen, Christina Demuth, Amanda Frydendahl,

Annals of Oncology

2023

67

Correlation between circulating mutant DNA and metabolic tumour burden in advanced non-small cell lung cancer patients

Anne Winther‐Larsen, Christina Demuth, Joan Fledelius,

British Journal of Cancer

2017

55

The T790M resistance mutation in EGFR is only found in cfDNA from erlotinib-treated NSCLC patients that harbored an activating EGFR mutation before treatment

Christina Demuth, Anne Tranberg Madsen, Britta Weber,

BMC Cancer

2018

41

Correlation between early dynamics in circulating tumour DNA and outcome from FOLFIRI treatment in metastatic colorectal cancer

Iben Lyskjær, Camilla Kronborg, Mads H. Rasmussen,

Scientific Reports

2019

38

Increased PD-L1 expression in erlotinib-resistant NSCLC cells with <i>MET</i> gene amplification is reversed upon MET-TKI treatment

Christina Demuth, Morten Nørgaard Andersen, Kristine Raaby Jakobsen,

Oncotarget

2017

35

Error Characterization and Statistical Modeling Improves Circulating Tumor DNA Detection by Droplet Digital PCR

Tenna Vesterman Henriksen, Simon Opstrup Drue, Amanda Frydendahl,

Clinical Chemistry

2021

30

Page 1